SHANGHAI GENTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.08 CNY | -4.65% |
|
-7.49% | -8.96% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,153 | 6,631 | 9,016 | 10,943 | 10,076 | - | - |
| Enterprise Value (EV) 1 | 5,153 | 6,631 | 9,016 | 10,943 | 10,076 | 10,076 | 10,076 |
| P/E ratio | 34.6 x | 39.2 x | 34.6 x | 27 x | 17.1 x | 13 x | 10.5 x |
| Yield | - | - | - | - | 0.8% | 0.8% | 0.8% |
| Capitalization / Revenue | - | 3.61 x | 3.33 x | 2.85 x | 1.75 x | 1.45 x | 1.15 x |
| EV / Revenue | - | 3.61 x | 3.33 x | 2.85 x | 1.75 x | 1.45 x | 1.15 x |
| EV / EBITDA | - | 30.5 x | 28.9 x | 21.3 x | 13.7 x | 10.4 x | 8.67 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | 3.56 x | 3.86 x | 3.65 x | 2.88 x | 2.45 x | 1.99 x |
| Nbr of stocks (in thousands) | 256,500 | 256,500 | 265,579 | 276,136 | 279,255 | - | - |
| Reference price 2 | 20.09 | 25.85 | 33.95 | 39.63 | 36.08 | 36.08 | 36.08 |
| Announcement Date | 21-04-19 | 22-02-25 | 23-02-13 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,837 | 2,705 | 3,835 | 5,761 | 6,958 | 8,729 |
| EBITDA 1 | - | 217.1 | 312.2 | 513 | 735.5 | 964.5 | 1,162 |
| EBIT 1 | - | 183.1 | 265.8 | 440.1 | 647 | 860.1 | 1,061 |
| Operating Margin | - | 9.97% | 9.83% | 11.47% | 11.23% | 12.36% | 12.15% |
| Earnings before Tax (EBT) 1 | - | 183.3 | 268 | 440.2 | 647.5 | 861.2 | 1,062 |
| Net income 1 | 124.3 | 168.4 | 258.7 | 401.7 | 596.5 | 784.7 | 976 |
| Net margin | - | 9.17% | 9.56% | 10.47% | 10.35% | 11.28% | 11.18% |
| EPS 2 | 0.5800 | 0.6600 | 0.9800 | 1.470 | 2.105 | 2.777 | 3.445 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.2900 | 0.2900 | 0.2900 |
| Announcement Date | 21-04-19 | 22-02-25 | 23-02-13 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 9.37% | 12.9% | 14.9% | 16.9% | 18.8% | 19% |
| ROA (Net income/ Total Assets) | - | - | - | - | 5.95% | 6.45% | 6.8% |
| Assets 1 | - | - | - | - | 10,025 | 12,166 | 14,353 |
| Book Value Per Share 2 | - | 7.270 | 8.800 | 10.90 | 12.50 | 14.80 | 18.20 |
| Cash Flow per Share 2 | - | -0.0800 | -0.5900 | 0.4100 | 0.6900 | 0.9500 | 1.120 |
| Capex 1 | - | - | - | 358 | 193 | 195 | 169 |
| Capex / Sales | - | - | - | 9.33% | 3.35% | 2.8% | 1.94% |
| Announcement Date | 21-04-19 | 22-02-25 | 23-02-13 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
36.08
CNY
Average target price
51.5
CNY
Spread / Average Target
+42.74%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.96% | 1.39B | |
| +16.68% | 87.2B | |
| +21.80% | 72.13B | |
| +18.00% | 36.82B | |
| +25.04% | 34.67B | |
| +12.66% | 28.34B | |
| +4.41% | 27.06B | |
| +6.88% | 26.98B | |
| +20.37% | 26.3B | |
| +20.64% | 25.5B |
- Stock Market
- Equities
- 688596 Stock
- Financials Shanghai GenTech Co., Ltd.
